Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Chondroitinase ABC plus bone marrow mesenchymal stem cells for repair of spinal cord injury

Chondroitinase ABC plus bone marrow mesenchymal stem cells for repair of spinal cord injury

Neural Regen Res, 2013 · DOI: 10.3969/j.issn.1673-5374.2013.11.001 · Published: April 1, 2013

Spinal Cord InjuryRegenerative Medicine

Simple Explanation

This study explores a new method for treating spinal cord injuries by combining chondroitinase ABC, which improves the environment around the injury, with bone marrow mesenchymal stem cells, which can help repair damaged tissue. Rats with spinal cord injuries were treated with either stem cells alone, chondroitinase ABC alone, or a combination of both. The combination treatment showed the best results in terms of improved motor function and reduced tissue damage. The study suggests that using chondroitinase ABC to create a better environment for stem cells can significantly improve the repair of spinal cord injuries.

Study Duration
Not specified
Participants
24 Sprague-Dawley rats
Evidence Level
Level 5, Animal Study

Key Findings

  • 1
    The combination group showed significantly higher Basso, Beattie and Bresnahan scores at 14 days after spinal cord injury, indicating improved motor function compared to other groups.
  • 2
    Hematoxylin-eosin staining revealed that the necrotic area was significantly reduced in the combination group compared with the model, bone marrow mesenchymal stem cell, and chondroitinase ABC groups.
  • 3
    Glial fibrillary acidic protein/growth associated protein-43 double immunostaining showed that positive fibers traversed the damage zone in the combination group, suggesting enhanced axonal growth.

Research Summary

This study investigated the combined effects of chondroitinase ABC and bone marrow mesenchymal stem cell transplantation on spinal cord injury repair in rats. The combination therapy resulted in improved motor function, reduced necrotic areas, and enhanced axonal growth compared to individual treatments. The findings suggest that chondroitinase ABC creates a more favorable microenvironment for stem cell transplantation, leading to better spinal cord injury repair.

Practical Implications

Clinical Application

The combination therapy may offer a novel approach for treating spinal cord injuries in humans, potentially improving motor function and reducing tissue damage.

Microenvironment Importance

The study highlights the significance of the microenvironment in spinal cord injury repair and suggests that modifying the environment can enhance the effectiveness of cell transplantation.

Further Research

Further studies are needed to elucidate the specific mechanisms by which chondroitinase ABC and bone marrow mesenchymal stem cells interact to promote spinal cord regeneration.

Study Limitations

  • 1
    Animal model may not fully represent human spinal cord injury.
  • 2
    The study only examined the effects of the treatment at 14 days after injury.
  • 3
    The specific mechanisms of the combination therapy require further investigation.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury